Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection (eXcision)
A Single Centre Pilot Study Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Oludolapo Adesanya
- Phone Number: +44 (0)2476968212
- Email: Oludolapo.Adesanya@uhcw.nhs.uk
Study Locations
-
-
-
Coventry, United Kingdom, CV2 2DX
- University Hospitals Coventry and Warwickshire NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
For prostate cancer patients:
- At least 18 years old at time of consent.
- Listed for Robotic Radical Prostatectomy.
For head and neck cancer patients:
- At least 18 years old at time of consent.
- Listed for resection of oral squamous cell carcinoma head and neck cancer resection.
- Specimen able to fit into Xeos Aura specimen container.
Exclusion Criteria:
For prostate cancer patients:
- General or local contra-indications for resectional surgery.
- Lacks capacity to provide informed consent.
- Currently participating in another interventional research study that in the judgment of the investigator would negatively affect the participant and/or this study's data integrity.
For head and neck cancer patients:
- General or local contra-indications for resectional surgery.
- Lacks capacity to provide informed consent.
- Pregnant or breast feeding patient.
- Currently participating in another interventional research study that in the judgment of the investigator would negatively affect the participant and/or this study's data integrity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Radical prostatectomy and Head and neck specimens
Patients undergoing surgical resection for prostate cancer or head and neck cancer.
|
Participants will be injected with a small amount of radioactive tracer at the beginning of their cancer operation.
This tracer will attach itself to the cancer cells.
Once the surgical specimen is removed it will be placed into the specimen PET-CT scanner so that the surgeon can see the cancer within the specimen and assess the margin.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the accuracy of intra-operative high-resolution surgical specimen PET-CT (XEOS Aura 10) in determining margin status during prostate cancer resection, and head and neck cancer resection specimens compared to the reference gold standard.
Time Frame: Up to 8 weeks after the day of surgery when the histopathological margin status result is recorded.
|
The true gold standard is whether the cancer is on the margin (positive) or not (negative) as per specimen PET-CT compared to the gold standard radical prostatectomy histopathological margin status, and head and neck cancer resection specimen.
|
Up to 8 weeks after the day of surgery when the histopathological margin status result is recorded.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OA641624
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.